发明名称 HETEROCYCLIC COMPOUNDS AS IMAGING PROBES OF TAU PATHOLOGY
摘要 Pyridazinone compounds of Formula I: (I) wherein: R' is alkyl or Ar, optionally substituted with at least one alkyl, halo¬ gen, hydroxyl, alkoxy, haloalkoxy, acid, ester, amino, nitro, amide, or alkoxyhalo; 2 R is independently alkyi, alkynyl, ester, amino, amide, acid, aryl, heteroaryl, aminoalkyl, -C(=0)alkyl, -C(=0)aryl, -C(=0)heteroaryl, -C(=0)heterocycloalkyl, - C(=0)heterocycloalkylAr, -C(=0)(CH2)nhalo, -C(=0)(CH2)nheterocyclyl, or -SC^Ar, optionally substituted with at least one alkyi, alkylhalo, halogen, nitro, aryl, heteroaryl, or heteroaryl(CH2)nhalo; R 3 and R4 are independently hydrogen, alkyi, alkenyl, alkynyl, aryl, heteroaryl; Ar is an aryl, heteroaryl, cycloalkyl, heterocycloalkyl group; n is an integer from 0-10; or a radiolabeled derivative thereof. The compounds are useful as imaging probes of Tau pathology in Alzheimer's disease are described. Compositions and methods of making such compounds are also described.
申请公布号 WO2013090497(A1) 申请公布日期 2013.06.20
申请号 WO2012US69367 申请日期 2012.12.13
申请人 GE HEALTHCARE LIMITED;MEDI-PHYSICS, INC. 发明人 JONES, CLARE;GLASER, MATTHIAS EBERHARD;WYNN, DUNCAN;NAIRNE, JAMES;MOKKAPATI, UMAMAHESHWAR P.;NEWINGTON, IAN, MARTIN;RANGASWAMY, CHITRALEKHA;JOSE, JINTO;JOHANSSON, SAGA
分类号 C07D213/74;A61K31/5025;A61P25/00;C07C243/22;C07D237/24;C07D495/04 主分类号 C07D213/74
代理机构 代理人
主权项
地址